What is the current valuation of the US pain patch market?

The US pain patch market was valued at $1800.0 Million in 2024. Read More

What is the projected market size for the US pain patch market by 2035?

The market is projected to reach $3300.0 Million by 2035. Read More

What is the expected CAGR for the US pain patch market during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 5.67%. Read More

Which application segment has the highest valuation in the US pain patch market?

The Joint Pain Relief segment had the highest valuation, ranging from $540.0 Million to $990.0 Million. Read More

What are the key product types in the US pain patch market?

Key product types include Medicated Patches, which had a valuation between $800.0 Million and $1500.0 Million. Read More

Which end user segment is projected to dominate the US pain patch market?

The Home Care segment is projected to dominate, with a valuation range of $540.0 Million to $990.0 Million. Read More

What distribution channel is expected to generate the most revenue in the US pain patch market?

The Offline distribution channel is expected to generate the most revenue, with a valuation between $720.0 Million and $1320.0 Million. Read More

Who are the key players in the US pain patch market?

Key players include Johnson & Johnson, Pfizer Inc., Bayer AG, and Mylan N.V. Read More

What is the valuation range for the Cold Patch segment in the US pain patch market?

The Cold Patch segment had a valuation range of $250.0 Million to $500.0 Million. Read More

How does the valuation of the Chronic Pain Relief segment compare to the Acute Pain Relief segment?

The Chronic Pain Relief segment ranged from $360.0 Million to $660.0 Million, while the Acute Pain Relief segment ranged from $270.0 Million to $490.0 Million. Read More

US Pain Patch Market

US Pain Patch Market Research Report By Application (Chronic Pain Relief, Acute Pain Relief, Muscle Pain Relief, Joint Pain Relief, Post-operative Pain Relief), By Product Type (Heat Patch, Cold Patch, Medicated Patch, Herbal Patch, Transdermal Patch), By End User (Hospitals, Clinics, Home Care, Pharmacies, Sports Facilities) and By Distribution Channel (Online, Offline, Pharmacies, Supermarkets, Specialty Stores) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.67%

2024 Market Size

$ 1,800 Million

2035 Market Size

$ 3,300 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/16116-HCR | Pages: 100 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Application (USD Million)
  1. 4.1.1 Chronic Pain Relief
  2. 4.1.2 Acute Pain Relief
  3. 4.1.3 Muscle Pain Relief
  4. 4.1.4 Joint Pain Relief
  5. 4.1.5 Post-operative Pain Relief
2. 4.2 Construction, BY Product Type (USD Million)
  1. 4.2.1 Heat Patch
  2. 4.2.2 Cold Patch
  3. 4.2.3 Medicated Patch
  4. 4.2.4 Herbal Patch
  5. 4.2.5 Transdermal Patch
3. 4.3 Construction, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Clinics
  3. 4.3.3 Home Care
  4. 4.3.4 Pharmacies
  5. 4.3.5 Sports Facilities
4. 4.4 Construction, BY Distribution Channel (USD Million)
  1. 4.4.1 Online
  2. 4.4.2 Offline
  3. 4.4.3 Pharmacies
  4. 4.4.4 Supermarkets
  5. 4.4.5 Specialty Stores
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson & Johnson (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Pfizer Inc. (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bayer AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Mylan N.V. (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Haleon plc (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Novartis AG (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Teva Pharmaceutical Industries Ltd. (IL)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 GSK plc (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 CONSTRUCTION, BY PRODUCT TYPE, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
16. 6.16 CONSTRUCTION, BY END USER, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pain Patch Market Segmentation

US Pain Patch Market By Application (USD Million, 2025-2035)

Chronic Pain Relief
Acute Pain Relief
Muscle Pain Relief
Joint Pain Relief
Post-operative Pain Relief

US Pain Patch Market By Product Type (USD Million, 2025-2035)

Heat Patch
Cold Patch
Medicated Patch
Herbal Patch
Transdermal Patch

US Pain Patch Market By End User (USD Million, 2025-2035)

Hospitals
Clinics
Home Care
Pharmacies
Sports Facilities

US Pain Patch Market By Distribution Channel (USD Million, 2025-2035)

Online
Offline
Pharmacies
Supermarkets
Specialty Stores

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”